568 related articles for article (PubMed ID: 31078139)
1. Efficacy of botulinum toxin in modifying spasticity to improve walking and quality of life in post-stroke lower limb spasticity - a randomized double-blind placebo controlled study.
Datta Gupta A; Visvanathan R; Cameron I; Koblar SA; Howell S; Wilson D
BMC Neurol; 2019 May; 19(1):96. PubMed ID: 31078139
[TBL] [Abstract][Full Text] [Related]
2. A systematic review: efficacy of botulinum toxin in walking and quality of life in post-stroke lower limb spasticity.
Gupta AD; Chu WH; Howell S; Chakraborty S; Koblar S; Visvanathan R; Cameron I; Wilson D
Syst Rev; 2018 Jan; 7(1):1. PubMed ID: 29304876
[TBL] [Abstract][Full Text] [Related]
3. BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.
Shaw L; Rodgers H; Price C; van Wijck F; Shackley P; Steen N; Barnes M; Ford G; Graham L;
Health Technol Assess; 2010 May; 14(26):1-113, iii-iv. PubMed ID: 20515600
[TBL] [Abstract][Full Text] [Related]
4. OnabotulinumtoxinA for the Treatment of Poststroke Distal Lower Limb Spasticity: A Randomized Trial.
Wein T; Esquenazi A; Jost WH; Ward AB; Pan G; Dimitrova R
PM R; 2018 Jul; 10(7):693-703. PubMed ID: 29330071
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin type A in post-stroke lower limb spasticity: a multicenter, double-blind, placebo-controlled trial.
Kaji R; Osako Y; Suyama K; Maeda T; Uechi Y; Iwasaki M;
J Neurol; 2010 Aug; 257(8):1330-7. PubMed ID: 20358216
[TBL] [Abstract][Full Text] [Related]
6. The Effects of Botulinum Toxin Injections on Plantar Flexor Spasticity in Different Phases After Stroke: A Secondary Analysis From a Double-Blind, Randomized Trial.
Oh HM; Park GY; Choi YM; Koo HJ; Jang Y; Im S
PM R; 2018 Aug; 10(8):789-797. PubMed ID: 29510234
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin A for treatment of upper limb spasticity following stroke: a multi-centre randomized placebo-controlled study of the effects on quality of life and other person-centred outcomes.
McCrory P; Turner-Stokes L; Baguley IJ; De Graaff S; Katrak P; Sandanam J; Davies L; Munns M; Hughes A
J Rehabil Med; 2009 Jun; 41(7):536-44. PubMed ID: 19543664
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of botulinum toxin type A on gait and quality of life in adult post-stroke patients with lower limb spasticity: a systematic review protocol.
Chu WH; Gupta AD
JBI Database System Rev Implement Rep; 2016 Jun; 14(6):23-9. PubMed ID: 27532646
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of NABOTA in post-stroke upper limb spasticity: a phase 3 multicenter, double-blinded, randomized controlled trial.
Nam HS; Park YG; Paik NJ; Oh BM; Chun MH; Yang HE; Kim DH; Yi Y; Seo HG; Kim KD; Chang MC; Ryu JH; Lee SU
J Neurol Sci; 2015 Oct; 357(1-2):192-7. PubMed ID: 26233808
[TBL] [Abstract][Full Text] [Related]
10. Botulinum Toxin Type A Improves Function According to Goal Attainment in Adults with Poststroke Lower Limb Spasticity in Real Life Practice.
López de Munain L; Valls-Solé J; Garcia Pascual I; Maisonobe P;
Eur Neurol; 2019; 82(1-3):1-8. PubMed ID: 31726452
[TBL] [Abstract][Full Text] [Related]
11. Poststroke Postural Sway Improved by Botulinum Toxin: A Multicenter Randomized Double-blind Controlled Trial.
Kerzoncuf M; Viton JM; Pellas F; Cotinat M; Calmels P; Milhe de Bovis V; Delarque A; Bensoussan L
Arch Phys Med Rehabil; 2020 Feb; 101(2):242-248. PubMed ID: 31469982
[TBL] [Abstract][Full Text] [Related]
12. Goal attainment scaling in the evaluation of treatment of upper limb spasticity with botulinum toxin: a secondary analysis from a double-blind placebo-controlled randomized clinical trial.
Turner-Stokes L; Baguley IJ; De Graaff S; Katrak P; Davies L; McCrory P; Hughes A
J Rehabil Med; 2010 Jan; 42(1):81-9. PubMed ID: 20111849
[TBL] [Abstract][Full Text] [Related]
13. Rationale and design of a multicentre, double-blind, prospective, randomized, European and Canadian study: evaluating patient outcomes and costs of managing adults with post-stroke focal spasticity.
Borg J; Ward AB; Wissel J; Kulkarni J; Sakel M; Ertzgaard P; Åkerlund P; Reuter I; Herrmann C; Satkunam L; Wein T; Girod I; Wright N;
J Rehabil Med; 2011 Jan; 43(1):15-22. PubMed ID: 21174051
[TBL] [Abstract][Full Text] [Related]
14. Botuloscope: 1-year follow-up of upper limb post-stroke spasticity treated with botulinum toxin.
Marque P; Denis A; Gasq D; Chaleat-Valayer E; Yelnik A; Colin C; ; Pérennou D
Ann Phys Rehabil Med; 2019 Jul; 62(4):207-213. PubMed ID: 31229700
[TBL] [Abstract][Full Text] [Related]
15. The Complex Role of Botulinum Toxin in Enhancing Goal Achievement for Post-Stroke Patients.
Săndulescu MI; Cinteză D; Poenaru D; Potcovaru CG; Păunescu H; Coman OA
Toxins (Basel); 2024 Mar; 16(4):. PubMed ID: 38668597
[TBL] [Abstract][Full Text] [Related]
16. Effects of botulinum toxin A in ambulant adults with spastic cerebral palsy: a randomized double-blind placebo controlled-trial.
Maanum G; Jahnsen R; Stanghelle JK; Sandvik L; Keller A
J Rehabil Med; 2011 Mar; 43(4):338-47. PubMed ID: 21305227
[TBL] [Abstract][Full Text] [Related]
17. Effects of botulinum toxin A therapy and multidisciplinary rehabilitation on lower limb spasticity classified by spastic muscle echo intensity in post-stroke patients.
Hara T; Abo M; Hara H; Kobayashi K; Shimamoto Y; Shibata Y; Sasaki N; Yamada N; Niimi M
Int J Neurosci; 2018 May; 128(5):412-420. PubMed ID: 28985683
[TBL] [Abstract][Full Text] [Related]
18. Evaluating the functional outcomes of ultrasound-guided botulinum toxin type A injections using the Euro-musculus approach for upper limb spasticity treatment in post-stroke patients: an observational study.
Buyukavci R; Akturk S; Ersoy Y
Eur J Phys Rehabil Med; 2018 Oct; 54(5):738-744. PubMed ID: 29422486
[TBL] [Abstract][Full Text] [Related]
19. Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: a randomised double blind placebo controlled trial.
Bhakta BB; Cozens JA; Chamberlain MA; Bamford JM
J Neurol Neurosurg Psychiatry; 2000 Aug; 69(2):217-21. PubMed ID: 10896696
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin type A for the treatment of the upper limb spasticity after stroke: a meta-analysis.
Cardoso E; Rodrigues B; Lucena R; Oliveira IR; Pedreira G; Melo A
Arq Neuropsiquiatr; 2005 Mar; 63(1):30-3. PubMed ID: 15830061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
